Literature DB >> 29050399

Diagnostic criteria for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS).

W Oliver Tobin1, Yong Guo1, Karl N Krecke2, Joseph E Parisi3, Claudia F Lucchinetti1, Sean J Pittock1,3, Jay Mandrekar4, Divyanshu Dubey1,3, Jan Debruyne5, B Mark Keegan1.   

Abstract

Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) is a central nervous system inflammatory syndrome predominantly affecting the brainstem, cerebellum, and spinal cord. Following its initial description, the salient features of CLIPPERS have been confirmed and expanded upon, but the lack of formalized diagnostic criteria has led to reports of patients with dissimilar features purported to have CLIPPERS. We evaluated clinical, radiological and pathological features of patients referred for suspected CLIPPERS and propose diagnostic criteria to discriminate CLIPPERS from non-CLIPPERS aetiologies. Thirty-five patients were evaluated for suspected CLIPPERS. Clinical and neuroimaging data were reviewed by three neurologists to confirm CLIPPERS by consensus agreement. Neuroimaging and neuropathology were reviewed by experienced neuroradiologists and neuropathologists, respectively, both of whom were blinded to the clinical data. CLIPPERS was diagnosed in 23 patients (18 male and five female) and 12 patients had a non-CLIPPERS diagnosis. CLIPPERS patients' median age of onset was 58 years (interquartile range, 24-72) and were followed a median of 44 months (interquartile range 38-63). Non-CLIPPERS patients' median age of onset was 52 years (interquartile range, 39-59) and were followed a median of 27 months (interquartile range, 14-47). Clinical symptoms of gait ataxia, diplopia, cognitive impairment, and facial paraesthesia did not discriminate CLIPPERS from non-CLIPPERS. Marked clinical and radiological corticosteroid responsiveness was observed in CLIPPERS (23/23), and clinical worsening occurred in all 12 CLIPPERS cases when corticosteroids were discontinued. Corticosteroid responsiveness was common but not universal in non-CLIPPERS [clinical improvement (8/12); radiological improvement (2/12); clinical worsening on discontinuation (3/8)]. CLIPPERS patients had brainstem predominant perivascular gadolinium enhancing lesions on magnetic resonance imaging that were discriminated from non-CLIPPERS by: homogenous gadolinium enhancing nodules <3 mm in diameter without ring-enhancement or mass effect, and homogenous T2 signal abnormality not significantly exceeding the T1 enhancement. Brain neuropathology on 14 CLIPPERS cases demonstrated marked CD3-positive T-lymphocyte, mild B-lymphocyte and moderate macrophage infiltrates, with perivascular predominance as well as diffuse parenchymal infiltration (14/14), present in meninges, white and grey matter, associated with variable tissue destruction, astrogliosis and secondary myelin loss. Clinical, radiological and pathological feature define CLIPPERS syndrome and are differentiated from non-CLIPPERS aetiologies by neuroradiological and neuropathological findings.
© The Author (2017). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  CNS infection; T-lymphocytes; biomarkers; neuroinflammation; white matter lesion

Mesh:

Substances:

Year:  2017        PMID: 29050399     DOI: 10.1093/brain/awx200

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  34 in total

1.  NMDAR antibody encephalitis overlapping with CLIPPERS syndrome in a psoriasis patient on adalimumab.

Authors:  Talora Martin; Sean Duke; Veena Kumar; Ali Fadhil; Rami Ibrahim; Kaitlin Palmer; Saad Yazdani; Michael Devereaux; Steven Gunzler; Alessandro Serra; Hesham Abboud
Journal:  J Neurol       Date:  2021-01-02       Impact factor: 4.849

Review 2.  Multiple sclerosis.

Authors:  Massimo Filippi; Amit Bar-Or; Fredrik Piehl; Paolo Preziosa; Alessandra Solari; Sandra Vukusic; Maria A Rocca
Journal:  Nat Rev Dis Primers       Date:  2018-11-08       Impact factor: 52.329

3.  Hemidysgeusia, phantosmia and respiratory arrest: a case of CLIPPERS.

Authors:  Peter Baoviet Nguyen; David Prentice; Robert Brazel; Wai Kuen Leong
Journal:  BMJ Case Rep       Date:  2019-05-30

Review 4.  Atypical Pediatric Demyelinating Diseases of the Central Nervous System.

Authors:  Regina M Troxell; Alison Christy
Journal:  Curr Neurol Neurosci Rep       Date:  2019-11-26       Impact factor: 5.081

Review 5.  Brain miliary enhancement.

Authors:  Joseph C J Bot; Linda Mazzai; Rogier E Hagenbeek; Silvia Ingala; Bob van Oosten; Esther Sanchez-Aliaga; Frederik Barkhof
Journal:  Neuroradiology       Date:  2020-01-10       Impact factor: 2.804

6.  Area postrema involvement in chronic lymphocytic inflammation with pontine perivascular enhancement.

Authors:  Aigli Vakrakou; Vasilios Constantinides; George P Paraskevas; Kostas Kilidireas; Leonidas Stefanis; Elisabeth Kapaki
Journal:  Neurol Sci       Date:  2020-07-22       Impact factor: 3.307

7.  [CLIPPERS syndrome with supratentorial and spinal cord involvement and histological anomalies].

Authors:  Erik Ellwardt; Tristan Klodt; Clemens Sommer; Frank Birklein
Journal:  Nervenarzt       Date:  2019-12       Impact factor: 1.214

8.  Steroid pulse therapy of radiological disease activity without clinical relapse in CLIPPERS.

Authors:  Takashi Hosaka; Kiyotaka Nakamagoe; Naoki Tozaka; Satoshi Aizawa; Akira Tamaoka
Journal:  Neurol Sci       Date:  2019-09-03       Impact factor: 3.307

9.  Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids, a mimicker of malignancy: a case report and review of the literature.

Authors:  Eric Zhuang; Lisa Shane; Nima Ramezan; Ameera F Ismail; Nilesh L Vora
Journal:  J Med Case Rep       Date:  2021-05-18

10.  CLIPPERS associated with hypersensitivity pneumonitis: a case report.

Authors:  Maria Andrea Parra Corral; Jose Gavito-Higuera; Thomas O'Neill; Sajeev R Ezhapilli Chennan
Journal:  Radiol Case Rep       Date:  2021-07-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.